Clinical and experimental data indicated that eIF5A was overexpressed in CCA tissues and cells, and high expression of eIF5A showed poor survival and advanced disease stage in patients with CCA, indicating that eIF5A might be a potential prognostic indicator of CCA. This evidence concerns the gene EIF5A and cholangiocarcinoma.